Strata Critical Medical (SRTA) Free Cash Flow (2019 - 2026)

Strata Critical Medical has disclosed Free Cash Flow across 8 years of filings, most recently posting -$1.3 million for Q1 2026.

• In Q1 2026, Free Cash Flow fell 121.2% year-over-year to -$1.3 million; the TTM figure through Mar 2026 stood at -$49.8 million (down 277.87% YoY), while the FY2025 annual figure was -$49.0 million, down 1594.61% from the prior year.
• Free Cash Flow retreated to -$1.3 million in Q1 2026, from -$688000.0 in the prior quarter.
• Over the last five years, Free Cash Flow for SRTA reached as high as $24.2 million in Q4 2024 and fell as low as -$40.1 million in Q3 2025.
• The 5-year median for Free Cash Flow is -$7.2 million (2023), against an average of -$6.9 million.
• Annual changes were most pronounced in 2024 — Free Cash Flow jumped 433.92% — and 2025, when it tumbled 3199.84%.
• A 5-year view of Free Cash Flow shows it stood at -$22.3 million in 2022, then soared by 67.56% to -$7.2 million in 2023, then jumped by 433.92% to $24.2 million in 2024, then tumbled by 102.85% to -$688000.0 in 2025, then tumbled by 88.08% to -$1.3 million in 2026.
• According to Business Quant data, Free Cash Flow over the past three periods registered -$1.3 million, -$688000.0, and -$40.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.